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Solid lipid nanoparticles (SLNs) are a category of delivery systems applicable to various 
bioactive compounds in the food industry. Compared to conventional emulsions that have a 
fluidic oil phase, the mobility and release of bioactive compounds can be controlled by 
encapsulation in the solid lipid matrix with appropriate properties. Common approaches of 
preparing SLNs are high energy methods and solvent evaporation methods, which have can lead 
to degradation of compounds during processing and residues of organic solvent, respectively. In 
this thesis, a low energy approach based on the phase inversion temperature method has been 
used to prepare SLNs based on anhydrous milk fat (AMF). Food grade surfactant Tween 80 was 
used as a surfactant, and beta-carotene was used as a model lipophilic bioactive compound. AMF 
and surfactant solution with 0-1.0 M NaCl were mixed to form coarse emulsions that were 
heated at 80-95 °C [Celsius degree] for 30 min to induce phase inversion, followed by a fast 
cooling process in ice bath. The phase inversion temperature decreased from >95 °C to 73°C 
when NaCl increased from 0 to 1.0 M in the aqueous phase. Up to 10% w/w of AMF can be 
encapsulated in the system as transparent dispersions, with particle mean diameter smaller than 
25 nm. The SLN dispersions were dilution and dialysis stable, and the particle size and turbidity 
maintained unchanged during the 90-day storage at room temperature. Compared with beta-
carotene encapsulated in soybean oil-based nanoemulsion, degradation of beta-carotene in SLNs 
was much reduced. The studied SLNs may find unique applications in incorporating lipophilic 
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SLNs are nanoparticles that contain solid lipid cores. Like nanoemulsions, SLNs have a 
lot of advantages, for example, more stable, have better bioavailability, and have a relatively 
transparent appearance. Compared to nanoemulsions that have a fluidic oil phase, the mobility 
and release of bioactive compounds in SLNs can be controlled by encapsulation in the solid lipid 
matrix with appropriate properties. Approaches of preparing SLNs, high energy methods and low 
energy methods, and microemulsion based SLNs, have been compared and discussed in this 
review. Many factors may affect the stability of SLNs. Parameters used to characterize the 
stability of SLNs including particle size, zeta-potential, thermal and crystallization of lipids, and 
so on. In this literature review, bioactivity and bioavailability of bioactives incorporated in SLNs 
were also discussed. The studied SLNs may find unique applications in incorporating lipophilic 






Various delivery systems have been studied in recent years to incorporate lipophilic 
bioactive compounds for improved distribution, increased stability during processing and 
storage, and enhanced bioactivity or bioavailability 1. Oil-in-water (O/W) emulsions are 
commonly studied because the lipid core can serve as a carrier of lipophilic bioactives. 
Nanoemulsions have received extensive attention because, when compared with conventional 
emulsions that have a mean diameter in the range from 200 nm to 100 μm, the much smaller 
diameters (about 10-200 nm) of nanoemulsions offer several advantages 2. When particles are 
sufficiently small, thermal energy becomes more significant than gravitational energy. Therefore 
brownian motion is the main underlying force that cause the sedimentation due to density 
difference between the dispersed and continuous phases, which extends the shelf-life 3. Unlike 
the turbid appearance of conventional emulsions, nanoemulsions are usually translucent or 
transparent, due to the much reduced ability of nanoparticles to scatter visible light. As delivery 
systems, studies have shown the enhanced stability and bioavailability of bioactive compounds 
like beta-carotene, polymethoxyflavones, resveratrol, curcumin, and dibenzoylmethane after 
encapsulation in nanoemulsions 4.  
However, nanoemulsions have several limitations. For example, they are often stable 
only under a particular set of conditions and may be disintegrated upon dilution 5. Like 
conventional emulsions, coalescence and Ostwald ripening can result in the destabilization of 
nanoemulsions. When used to encapsulate compounds that can be degraded by environmental 
factors such as oxygen and light, the liquid state of the lipid core allows the diffusion of 




problematic for nanoemulsions because the small dimension of nanodroplets reduces the time 
scale to diffuse to droplet surface and provides a large surface area for reactions 6.  
Solid lipid nanoparticles (SLNs), possessing a solid lipid core, offer unique features 
overcoming some limitations but still maintain the advantages of nanoemulsions with a liquid 
core. Bioactive compounds in the solid lipid core have limited mobility and therefore lowered 
rate of diffusion to the particle surface 7. This can reduce the degradation of bioactive 
compounds by reactions such as exchange oxidation and therefore increase the chemical stability 
(Figure 1.1.). The protective properties of the incorporated active compounds of SLNs have been 
demonstrated for co-Q10 8. Finally, the solid state of lipid core can limit coalescence to improve 
physical stability during shelf-life storage. In this chapter, methods of preparing SLNs are 
discussed, followed by typical parameters used to characterize SLNs, before advancing to 
reviews about incorporation and release properties of bioactive compounds. Factors affecting the 
stability of SLNs, including physicochemistry of lipids and surfactants and preparation 
condition, are also discussed. 
 
2. Preparation of SLNs 
Various methods have been developed to prepare SLNs. Most techniques established to 
prepare nanoemulsions, high energy methods and low energy methods, can be used to prepare 
SLNs. In addition, SLNs can be manufactured by forming thermodynamically stable water-in-oil 
microemulsions at a temperature corresponding to the liquid state of lipids, followed by cooling 
to solidify the lipid core 2. The choice of a preparation method depends on the properties of lipids 




2.1. High energy emulsification methods 
The most common methods used to prepare SLNs are high energy methods, similar to 
those employed to prepare conventional nanoemulsions 9. Coarse emulsions are initially prepared 
and a mechanical device is then used to generate intense forces to disrupt the large oil droplets to 
fine ones. The established high-energy devices include high pressure homogenizers, 
microfluidizers, and high power sonication systems.  With respect to the melting temperature of 
lipids, high energy methods can be classified as being either melt (hot) and cold ones.  
2.1.1. High pressure homogenization (HPH) method 
HPH is a suitable method for preparation of SLNs. This method generates a disrupt force 
through a high pressure, and then the very high shear stress and cavitation forces disrupt the 
particles to very small size 10. Steps of preparing SLNs using melt and cold homogenization 
methods are summarized in Figure 1.2. 9.  
In melt, or hot, homogenization, bioactive compounds are dissolved or dispersed in melt 
lipid(s) first, and the hot lipid phase is mixed with a hot aqueous surfactant solution and stirred to 
form a coarse emulsion. The quality of coarse emulsion can significantly affect the quality of a 
final product. The coarse emulsions are then fed to a high pressure homogenizer and processed to 
fine nanoemulsions at temperatures above the melting point of lipids. SLNs are finally produced 
by cooling the nanoemulsions under controlled conditions 11. The diameter of SLNs processed 
using this method is about 80-300 nm, depending on chemistry and concentration of surfactants 
and lipid phase, temperature, and the pressure and number of passes during homogenization 12. 
The average size of SLNs may be increased by lipids by using higher melting temperatures and 




particles size can be obtained 14. This occurs because high temperatures decrease the viscosity of 
the dispersed phase 15.  
The hot HPH method is an effective approach to decrease particle size when preparing 
SLNs. However, its high temperature and shear stress have been assumed to be the major cause 
of free radical formation, which can cause the degradation of incorporated drug 15. When a 
bioactive compound is extremely temperature-sensitive, cold homogenization technique may 
become a more viable option 12b. To support, there are also studies reporting the activity of 
peptides did not change after cold homogenization 16. In this approach, lipids are heated and then 
mixed with bioactive compounds, followed by cryo-processing in liquid nitrogen or dry ice. The 
frozen mixture is then milled to reduce dimension, followed by its dispersal in a cold surfactant 
solution and subsequent HPH treatment to form SLNs 17. Besides reducing the degradation of 
encapsulated compounds, cold homogenization has two addition advantages. First, it can prevent 
the formation of super-cooled melts that are liquid lipids at temperatures below the 
crystallization point. Super-cooled melts formed due to the small particle dimension and the 
effect of surfactant(s). This is because lipids are precooled to form solids before HPH. Second, 
cryo-processing solidifies the melt rapidly, which results in a homogenous distribution of 
bioactive compounds in the lipid phase and avoids the expulsion from the lipid core as observed 
in melt homogenization 18. Effects of HPH on the structure of SLNs and encapsulated 
compounds are discussed in greater details below. 
2.1.2. Combination of high shear homogenization and ultrasonication methods 
High shear homogenization and ultrasound methods are other high energy methods that 




methods are well developed and easy to handle. However, metal contamination due to ultra-
sonication is a potential problem 19. Typically, a coarse emulsion is first prepared with an 
ultrasonic instrument, and high speed stirring is used to further reduce particle size 20. It was also 
reported that a higher shear rate during homogenization did not significantly change particle size 
but decreased the polydispersity index of emulsions 21. In another study, Sliva et al. 22 compared 
risperidone SLNs prepared by hot HPH and ultrasound technique. The authors did not observe 
significant difference in the dimension and shape of particles prepared by the two methods. 
SLNs produced by HPH however demonstrated better physical stability and a higher drug-
loading capacity. 
2.1.3. Supercritical fluid extraction methods 
A novel supercritical fluid extraction of emulsions (SFEE) method has also been 
developed to produce SLNs to encapsulate drugs 23. This method is based on the principle that 
supercritical fluids can extract an organic solvent from a pre-formed lipid dispersion 24. A carrier 
lipid and a lipophilic drug are first dissolved in chloroform, which is then mixed with an aqueous 
phase with surfactants. The coarse emulsion can be processed to fine oil droplets by HPH. The 
fine emulsion is then sprayed into a continuous extraction chamber for extraction by a counter-
flow supercritical carbon dioxide (Figure 1.3.). SLNs with a narrow size distribution and a mean 
diameter below 30 nm were reported, and the residual solvent content in the final dispersion was 
consistently low (below 20 ppm). For food applications, the organic solvent may be adopted for 




2.2. Low energy emulsification methods 
In low-energy approaches, the formation of tiny oil droplets within oil-water-emulsifier 
mixture systems is spontaneous when the composition or environmental conditions are altered 2. 
In the solvent evaporation method, lipids and the compound to be encapsulated are first 
dissolved in an organic solvent such as ethanol and acetone. After formation of a coarse 
emulsion, the organic solvent is evaporated, e.g., at a temperature above the melting point of 
lipids, to reduce the particle size, followed by cooling to form SLNs 25. The approach has also 
been used to prepare W/O/W SLNs 26. A problem of this method is the low concentration of 
lipids in preparation, because a limited concentration of lipids can be dissolved in the organic 
solvent. The organic solvent residue is another limitation for food applications. 
Theoretically, all low energy approaches used to prepare nanoemulsions can be used to 
prepare SLNs by adopting a cooling step. For example, the phase inversion temperature method, 
which involves a heating step and another cooling process, may be adopted to prepare SLNs. 
However, these low energy methods are not well studied for the preparation of SLNs. 
2.3. Microemulsion-based SLNs 
Besides adopting techniques used to prepare nanoemulsions, SLNs can be developed 
from microemulsions. Principally, warm microemulsions are first prepared with a melt lipid 
core, followed by dilution into cold water under stirring to solidify the lipid core in order to form 
SLNs. The diluted emulsion can be concentrated by ultrafiltration or freeze drying 27. 
Microemulsion-based SLNs preparations do not involve high energy to reduce the particle size, 




is required to prepare microemulsions, and the final process of concentrating SLNs may promote 
the aggregation of SLNs and thus affect their dimension 28.  
3. Factors affect stability of SLNs and their measurements 
Stability of SLNs system is affected by many factors, including chemical and thermal 
properties of lipid phase, type and amount of surfactant, and preparation and storage conditions, 
which will described below. To characterize the effects of these factors, particle size, zeta 
potential and other measurements are used. The adequate characterization of these parameters of 
SLNs is also significant to control the quality of product. 
3.1. Particle size 
Particle size affects both the stability and appearance of colloidal systems. Typically, 
colloidal systems with small particle size are more stable and have clearer appearance 29. For 
example, delivery systems with particle diameters less than 60-80 nm are transparent but become 
turbid or opaque at larger particle size 30. Thus, optical clarity can be used to characterize the 
stability of systems with small particles 5. Many factors affect the dimension of SLNs. The 
choice of lipid(s) is one of the key parameters in controlling the properties and structure of 
SLNs. For example, the average size of SLNs can be decreased by lipids with higher melting 
temperatures 13a. This is due to the higher viscosity of lipid core during hot homogenization. 
Increasing the lipid content also increases particle size and broadens the particle size distribution 
13b. 
In emulsion systems, surfactant type and concentration also have a great effect on particle 
size and storage stability. Surfactants decrease interfacial tension and provide sufficient repulsive 




by melt methods, the effect of emulsifier is of the same importance to properties of SLNs as to 
nanoemulsions. For tripalmitin SLNs prepared using melt HPH method 31, when stored at a 
temperature lower than 20 °C, gelation of SLNs stabilized with modified starch was retarded 
compared with those coated with Tween 20. This is due to the formation of a thick polymeric 
layer around the lipid particles that inhibited partices from aggregating. But the gelation would 
still occur eventually for SLNs coated with modified starch. While when stored at 37 °C, SLNs 
coated with Tween 20 showed a longer stability against aggregation and gelation, which may due 
to the not fully crystallized lipid core compared with the fully crystallized lipid core of modified 
starch coted SLNs. 
Other preparation conditions may also affect the physical stability of SLNs. SLNs with 
Compritol 888 ATO as lipid carrier were prepared using hot HPH method 32. The energy 
introduced to this system (temperature, light) led to particle size growth and gelation, also to an 
increase in zeta potential. On the other hand, packing material (siliconized vials of glass quality) 
did not show pronounced effect on the stability of SLNs.  
Dynamic light scattering (DLS) is the most commonly used method to measure particle 
size of colloidal systems. In DLS, the fluctuation of the intensity of the scattered light, due to the 
Brownian motion of particles, is measured 33, and the hydrodynamic radius of individual 
particles can be determined via the Stokes-Einstein equation 34. The hydrodynamic radius of a 
dispersion can be obtained as the average of individual hydrodynamic radii after weighing their 
scattered light intensities 35. This method can be used to measure particles with a dimension from 




However, it should be noted that DLS does not measure particle size directly and the 
assumption of “infinite dilution” 33 is difficult to fulfill. Therefore, additional techniques are 
recommended to complement DLS studies, for example, scanning electron microscopy (SEM), 
transmission electron microscopy (TEM), and atomic force microscopy (AFM). The advanced 
microscopy techniques provide not only particle dimensions but also additional information such 
as particle morphology.  
3.2. Surface charge  
Many polymers used to prepare emulsions, for example, proteins and polysaccharides, 
are charged. Information of the electrical charge of particles in a delivery system is of great 
importance. Particle charge affects interpartilce against aggregation, binding with biological 
surfaces, and interactions with other ingredients in a food matrix 29b. 
Surface charge properties of SLNs are important to the stability because of their 
significance on the long-range electrostatic repulsion between SLNs. Surface charge of a 
colloidal system is usually measured for zeta potential. Generally, dispersions with a zeta-
potential magnitude higher than 30 mV are physically stabilized by electrostatic repulsion alone 
36. A zeta-potential as low as 8-9 mV in combination with a steric stabilization was also reported 
to stabilize SLNs in artificial gastrointestinal media 37.  
3.3. Crystallization and thermal properties 
Lipids used to prepare SLNs include triglycerides (e.g. tristearin), partial glycerides (e.g. 
Imwitor), fatty acids (e.g. stearic acid), steroids (e.g. cholesterol), and waxes (e.g. cetyl 
palmitate) 38. Thermal properties and crystalline characteristics of bulk lipid and prepared SLNs 




and release rates of bioactive compounds 39. The melting point of core lipid also influences the 
preparation temperature, the cooling temperature, and cooling rate in the melt HPH method. The 
lipid composition may also affect loading parameters 7, 13b. 
Crystallization behavior of lipids in SLNs is different from bulk lipids. The solidification 
temperature of lipid core in SLNs may be lower than that of the bulk lipids 9. Nanoparticles 
prepared from bulk lipids that are solid at room temperature can exist as super-cooled melts at 
room and even refrigeration temperatures over several months 40. Thus, some nanoparticles 
prepared from lipids that are solid at room temperature may not be considered as SLNs due to 
the present of super-cooled melts at room and refrigerator temperature.   
The main reason of formation of supercooled melts is the nano-scale size of SLNs. The 
presence of nuclei is a prerequisite of crystallization 41, and the formation of a sufficient number 
of nuclei is less possible in nanoparticles. Besides the small size of nanoparticles, surfactants 
play an additional role in controlling crystallization process because the number of lipid 
molecules interacting with the hydrophobic emulsifier tail groups can be large enough to 
modulate the crystallization properties. Thus, surfactant chemistry can affect both melting point 
and melting enthalpy of lipids 42. Saturated phospholipids can increase the crystallization 
temperature, thus promote crystallization of SLNs at a higher temperature during cooling 
process42. Egg lecithin was also reported to induce crystallization at higher temperatures than 
soybean lecithin 43.  
The lipid composition also determines polymorphisms of lipid crystals (Figure 1.4). The 
β-form crystals are thermodynamically more stable than the α-form crystals and have the highest 




transformation of the lipid crystal leads to an overall morphological change of the lipid particles 
from a spherical to a needle-like shape, which increases the total surface area. During the 
transformation, non-polar lipid surfaces are exposed to water, which, if surfactant present is 
insufficient, can causes aggregation of lipid particles to reduce the unfavorable contact between 
oil and water 44. As described above, this process can cause precipitation or gelation after certain 
storage period. To prove this mechanism, additional surfactant was added to the aqueous phase 
prior to crystallization of the lipid phase but after the homogenization 45. In this way, droplet size 
was maintained because additional surfactant can interact with the newly formed surfaces during 
transformation of crystal polymorphisms, and the SLNs dispersions remained fluid-like, 
contrasting with the gel formation of the control group.  
Chemical properties of surfactant, lipid phase, and preparation conditions all have an 
effect on the polymorphic transition behavior of lipids. Mixing tripalmitin with medium chain 
triglycerides or short chain lipid (orange oil) can slow the transition process and improve the 
stability of SLNs against particle aggregation and gelation 31. The lipid transition would also 
related to surfactant type used. SLNs prepared form high melting surfactants (high melting 
lecithin and Tween 60) had a higher α crystal fraction than SLNs prepared form low melting 
surfactants (low melting lecithin and Tween 80) 46. The polymorphic transitions of triglycerides 
can be slowed by the presence of saturated lecithin as emulsifier 43. When preparing SLNs with 
hot HPP approaches, cooling and heating conditions are important parameters to control crystal 
structure. Figure 1.5 shows the effect of cooling conditions on crystal structure. The α-form 
crystals are formed around 43 ℃ while β-crystals are usually formed around 61 ℃ 34. When 
cooling speed changes, the crystal type formed can also change. A fast cooling rate favors the 




preferred for the stability of SLNs. Heating and cooling rates also affect the transition of SLNs 
from α to β polymorphic forms, which is related to particle aggregation and gelation. A fast 
cooling rate decreases the gelation temperature during cooling, while a fast heating rate increases 
the gelation temperature during heating. Fast cooling and heating rates also decrease coalescence 
enthalpy, but favor the formation of supercooled melt. Thus, careful selections of cooling and 
heating rates are required to form stable SLNs suspensions 47.  
Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) are widely used to 
investigate the structure of lipids. In DSC, thermal properties are measured based on the fact that 
lipid structures formed at various conditions possess different melting points and melting 
enthalpies. Conversely, XRD can used to study the existence and type of crystalline structures 48. 
These two methods are usually combined to determine the melting point, melting enthalpy, 
crystal type, crystal transformation and solid state of lipids in SLNs 49.  
4. Release and bioavailability of bioactives incorporated in SLNs 
Many SLNs systems have been developed for topical applications, oral administration 
and parenteral administration of bioactives, listed in Table 1. SLNs systems developed for food 
applications are rare compared with SLNs for pharmaceutical and cosmetic applications. 
However, many drugs are loaded in SLNs using food grade lipids and emulsifiers (lecithin, 
Tween, and so on) 12c, which can be used to guide studies targeted for food applications. Physical 
stability of SLNs and stability, incorporation, release, and bioavailability of drugs loaded in 
SLNs are significant parameters to be considered to study these systems.  
Three types of SLNs have been developed to incorporate active ingredients: homogenous 




models are due to the partitioning of drug between lipid phase and aqueous surfactant phase 
during particle formation. The homogenous matrix model is thought to be formed when applying 
a cold homogenization method or when incorporating very lipophilic drugs, while the other two 
models are obtained due to phase separation and fast precipitation of drugs during the cooling 
process, respectively 18. When producing SLNs by hot methods, drugs are first loaded in melt 
lipids and tend to partition to the aqueous phase. When temperature rises or when surfactant 
concentration increases, the solubility of drugs in the aqueous phase increases, resulting in the 
increased drug partitioning to the aqueous phase. During cooling, the solubility of drugs in the 
aqueous phase decreases and drugs start to repartition to the lipid phase. When temperature 
reaches the recrystallization temperature, a solid lipid core starts to form, incorporating drugs 
with an amount depending on the solubility of drugs. Upon further cooling, drugs can continue to 
partition to the lipid phase but the already-solidified lipid core cannot incorporate anymore 
drugs, forming the outer shell rich in drugs. Lastly, SLNs with a drug-enriched core are formed 
when the drug precipitates before lipids. This can occur in the case when dissolving a drug in 
lipid melts close to its saturation solubility. If drugs supersaturate in the lipid phase during 
cooling and crystallize before the lipids recrystallize. Further cooling leads to further 
crystallization of drugs until reaching the recrystallization temperature of lipids. In the final 
stage, a solid lipid shell forms around the solid core, resulting in SLNs with drug-enriched core 
12b.  
The properties of drugs being released from SLNs are a function of SLNs structures. 
When drugs are mostly in the shell (Figure 1.6), burst release is commonly observed 19; 51. In 
contrast, a prolonged release can also be achieved by forming SLNs with drug-rich cores or a 




Particle size (surface area) of SLNs greatly affects the extent of burst release 19, 50. 
Reduced burst release was observed with an increase in particle size, and a prolonged release can 
be obtained when the particle size is sufficiently large 17. In the drug-enriched shell model 
(Figure 1.6.), the drug in the outer shell has a relatively short distance of diffusion, resulting in a 
burst release. This was demonstrated for nisin encapsulated in SLNs, showing a high percentage 
of release in the first day but a prolonged release through the 25 day period 53. This enabled the 
antibacterial activity against Listeria monocytogenes and Lactobacillus plantarum for up to 20 
and 15 days, respectively, which was much longer than only the one and three-day activity for 
free nisin 53.  
During storage, α and β' type crystals can transform to more stable, ordered β type 
crystals 13b. The formation of highly crystallized lipid with perfect lattices can lead to drug 
expulsion and formation of drug crystals in the aqueous SLNs dispersions, resulting in increased 
drug degradation 58. To avoid drug exclusion, increase drug incorporation, and prolong drug 
release, lipid cores with multiple components can be adopted to increase the distance between 
fatty acid chains of the glycerides and decreases the perfectness of crystals. Hard fat is a mixture 
of partial glycerides and liquid fractions. SLNs based on hard fat tend to form the less structured 
lipid core that increases drug inclusion and avoids drug expulsion 54. This occurs because the 
impurities of lipids can retard the recrystallization process. A mixture of solid and liquid lipids 
can lead to more imperfections in the crystal, and thus can increase drug loading 55. Some 
researcher also call this kind of delivery systems nanostructured lipid matrices (NLC) 12b, which 
are solid but not crystalline. In general, the solubility of drugs in the lipid melt is higher than that 
in the final solid lipids. A high concentration of drugs leads to immediate drug expulsion during 




core (O/F/W type) has been developed 12b, 56. An increased drug loading was observed in this 
delivery systems because of the high solubility of drug in the liquid lipid. At the same time, the 
solid lipid around the liquid core can still protect drugs from degradation, as in other SLNs 
systems. 
Other factors affecting drug release include drug chemistry, emulsifier type and 
concentration, the nature of lipid matrix, and preparation methods 51, 57. SLNs stabilized by high-
melting surfactants were observed to protect the encapsulated beta-carotene against chemical 
degradation better than those with lower melting temperatures 58. This occured because high-
melting surfactants can affect the polymorphic transition behavior of lipids to form more α-
crystals that not only improve the chemical stability but also accommodate a higher level of 
bioactive compounds 46, 58. The effects of drug chemistry were demonstrated in a study showing 
burst release of tetracaine and etomidate but prolonged release of prednisolone when these three 
compounds were incorporated in SLNs using the same production method 11a. 
The high temperature used in hot HPH method and high surfactant concentration can 
increase the burst release, which may be prevented by adopting the cold homogenization method 
18. The burst release can also be reduced by adopting a surfactant that does not dissolve drugs or 
possibly excluding surfactant in SLNs preparation.  Exceptions have also been observed. For 
example, proteins loaded in W/O/W SLNs prepared with the solvent evaporation method showed 
the reduced burst release at a higher surfactant concentration 59. This may have been caused by 
differences in SLNs structures, W/O/W in this study vs. no aqueous phase in regular SLNs. As 
for the lipid matrix, the structure can be engineered by blending medium chain triglycerides 




thus be obtained by a built-in trigger mechanism to initiate the transformation from α to β form 
crystals 55a, 56.  
The controlled release of drugs from SLNs has been studied in vitro and in vivo. For 
rifampicin, isoniazid, and pyrazinamide incorporated in SLNs using an “emulsion solvent 
diffusion” method, drug concentrations were maintained in the plasma for 8 days and in the 
organs for 10 days following the oral administration to mice. This contrasted with free drugs that 
were cleared in 1-2 days 25a. When tested for mice infected by M. tuberculosis H37Rv, delivery of 
drugs using SLNs reduced the dosing frequency 25a. A SLNs formulation of compritol for 
intravenous injection also showed reduced phagocytic uptake in vitro and in vivo, corresponding 
to the prolonged circulation time 61. Small interfering RNA (siRNA) loaded in SLNs also 
showed the prolonged release both in vivo and in vitro, and the in vitro cell studies showed that 
the released siRNA maintained its activity 62. Idarubicin loaded in SLNs and in the solution form 
was administered to rats by the duodenal route or intravenously 63. A prolonged release and 
higher bioavailability were observed for idarubicin loaded in SLNs when compared to the 
solution control. For the SLNs treatment, the drug and its metabolite were observed in the brain, 
which was not observed for the solution treatment. The ability of SLNs passing the blood-brain 
barrier was also reported in others studies, which suggests that the prolonged circulation time of 
SLNs causes the accumulation in the brain but not in other organs11b, 64. This characteristic, if 
carefully controlled, can be used for the targeted delivery of drugs using SLNs.  
5. Conclusions 
SLNs are a group of delivery systems with potential for application in the food industry. 




with modifications. SLNs can also be prepared from self-assembled microemulsions. The 
physical stability of SLNs can be controlled for particle dimension and surface charge, as well as 
the structures of lipid core including the composition and type of crystals. When compared to 
conventional emulsions, the mobility and release of bioactive compounds can be controlled by 
the properties of solid matrix and thus the degradation of bioactive compounds due to exchange 
can be reduced. The release properties of the encapsulated compounds, however, are dependent 
on the exact structure of SLNs, with burst release commonly observed for the presence of the 
encapsulated compound mostly in the outer shell and prolonged release corresponding to 
compounds rich in the lipid core or distributed evenly in the lipid matrix. There are several 
problems related to the stability and controlled drug release, including lipid crystal 
transformation, super-cooled melts, drug expulsion and degradation of incorporated drug during 
processing. These problems can usually be overcome by adopting appropriate lipid 

















1. McClements, D. J.; Decker, E. A.; Weiss, J., Emulsion‐Based Delivery Systems for 
Lipophilic Bioactive Components. J. Food Sci. 2007, 72 (8), R109-R124. 
2. McClements, D. J.; Rao, J., Food-grade nanoemulsions: formulation, fabrication, 
properties, performance, biological fate, and potential toxicity. Critical Reviews in Food Science 
and Nutrition 2011, 51 (4), 285-330. 
3. Uson, N.; Garcia, M. J.; Solans, C., Formation of water-in-oil (W/O) nano-emulsions in a 
water/mixed non-ionic surfactant/oil systems prepared by a low-energy emulsification method. 
Colloids and Surfaces A: Physicochemical and Engineering Aspects 2004, 250 (1-3), 415-421. 
4. Grolier, P.; Agoudavi, S.; Azais-Braesco, V., Comparative bioavailability of diet-, oil-and 
emulsion-based preparations of vitamin A and β-carotene in rat. Nutrition Research 1995, 15 
(10), 1507-1516. 
5. Li, Y.; Zheng, J.; Xiao, H.; McClements, D. J., Nanoemulsion-based delivery systems for 
poorly water-soluble bioactive compounds: Influence of formulation parameters on 
polymethoxyflavone crystallization. Food hydrocolloids 2012, 27 (2), 517-528. 
6. Donsì, F.; Sessa, M.; Mediouni, H.; Mgaidi, A.; Ferrari, G., Encapsulation of bioactive 





7. Rao, J.; McClements, D. J., Formation of Flavor Oil Microemulsions, Nanoemulsions 
and Emulsions: Influence of Composition and Preparation Method. Journal of Agricultural and 
Food Chemistry 2011. 
8. Magenheim, B.; Levy, M.; Benita, S., A new in vitro technique for the evaluation of drug 
release profile from colloidal carriers-ultrafiltration technique at low pressure. International 
Journal of Pharmaceutics 1993, 94 (1), 115-123. 
9. Benita, S.; Friedman, D.; Weinstock, M., Pharmacological evaluation of an injectable 
prolonged release emulsion of physostigmine in rabbits. Journal of pharmacy and pharmacology 
1986, 38 (9), 653-658. 
10. Benita, S.; Friedman, D.; Weinstock, M., Physostigmine emulsion: a new injectable 
controlled release delivery system. International Journal of Pharmaceutics 1986, 30 (1), 47-55. 
11. Weiss, J.; Decker, E. A.; McClements, D. J.; Kristbergsson, K.; Helgason, T.; Awad, T., 
Solid lipid nanoparticles as delivery systems for bioactive food components. Food Biophysics 
2008, 3 (2), 146-154. 
12. Schwarz, C., Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug 
incorporation and physicochemical characterization. Journal of microencapsulation 1999, 16 (2), 
205-213. 
13. Mehnert, W.; Mäder, K., Solid lipid nanoparticles: production, characterization and 




14. Schultz, S.; Wagner, G.; Urban, K.; Ulrich, J., High‐Pressure Homogenization as a 
Process for Emulsion Formation. Chemical engineering & technology 2004, 27 (4), 361-368. 
15. zur Mühlen, A.; Schwarz, C.; Mehnert, W., Solid lipid nanoparticles (SLN) for controlled 
drug delivery–drug release and release mechanism. European journal of pharmaceutics and 
biopharmaceutics 1998, 45 (2), 149-155. 
16. Yang, S. C.; Lu, L. F.; Cai, Y.; Zhu, J. B.; Liang, B. W.; Yang, C. Z., Body distribution 
in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on 
brain. Journal of Controlled Release 1999, 59 (3), 299-307. 
17. Jenning, V.; Gysler, A.; Schäfer-Korting, M.; Gohla, S. H., Vitamin A loaded solid lipid 
nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. European 
journal of pharmaceutics and biopharmaceutics 2000, 49 (3), 211-218. 
18. Müller, R.; Radtke, M.; Wissing, S., Nanostructured lipid matrices for improved 
microencapsulation of drugs. International Journal of Pharmaceutics 2002, 242 (1), 121-128. 
19. Hu, L.; Tang, X.; Cui, F., Solid lipid nanoparticles (SLNs) to improve oral bioavailability 
of poorly soluble drugs. Journal of pharmacy and pharmacology 2004, 56 (12), 1527-1535. 
20. De Labouret, A.; Thioune, O.; Fessi, H.; Devissaguet, J.; Puisieux, F., Application of an 
original process for obtaining colloidal dispersions of some coating polymers. Preparation, 





21. Westesen, K.; Bunjes, H.; Koch, M., Physicochemical characterization of lipid 
nanoparticles and evaluation of their drug loading capacity and sustained release potential. 
Journal of Controlled Release 1997, 48 (2), 223-236. 
22. Helgason, T.; Awad, T.; Kristbergsson, K.; McClements, D.; Weiss, J., Effect of 
surfactant surface coverage on formation of solid lipid nanoparticles (SLN). Journal of colloid 
and interface science 2009, 334 (1), 75-81. 
23. Lander, R.; Manger, W.; Scouloudis, M.; Ku, A.; Davis, C.; Lee, A., Gaulin 
homogenization: a mechanistic study. Biotechnology progress 2000, 16 (1), 80-85. 
24. Almeida, A. J.; Runge, S.; Müller, R. H., Peptide-loaded solid lipid nanoparticles (SLN): 
influence of production parameters. International Journal of Pharmaceutics 1997, 149 (2), 255-
265. 
25. Müller, R. H.; Mäder, K.; Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug 
delivery–a review of the state of the art. European journal of pharmaceutics and 
biopharmaceutics 2000, 50 (1), 161-177. 
26. Müller, R.; Radtke, M.; Wissing, S., Solid lipid nanoparticles (SLN) and nanostructured 
lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced drug delivery 
reviews 2002, 54, S131-S155. 
27. Wissing, S.; Kayser, O.; Müller, R., Solid lipid nanoparticles for parenteral drug delivery. 




28. Hou, D.; Xie, C.; Huang, K.; Zhu, C., The production and characteristics of solid lipid 
nanoparticles (SLNs). Biomaterials 2003, 24 (10), 1781-1785. 
29. Allouche, J.; Tyrode, E.; Sadtler, V.; Choplin, L.; Salager, J. L., Simultaneous 
conductivity and viscosity measurements as a technique to track emulsion inversion by the 
phase-inversion-temperature method. Langmuir 2004, 20 (6), 2134-2140. 
30. Ahlin, P.; Kristl, J.; Smid-Korbar, J., Optimization of procedure parameters and physical 
stability of solid lipid nanoparticles in dispersions. Acta pharmaceutica 1998, 48 (4), 259-267. 
31. Silva, A.; González-Mira, E.; García, M.; Egea, M.; Fonseca, J.; Silva, R.; Santos, D.; 
Souto, E.; Ferreira, D., Preparation, characterization and biocompatibility studies on risperidone-
loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. 
Colloids and surfaces B: Biointerfaces 2011, 86 (1), 158-165. 
32. Chattopadhyay, P.; Shekunov, B. Y.; Yim, D.; Cipolla, D.; Boyd, B.; Farr, S., Production 
of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) 
for pulmonary delivery using the AERx system. Advanced drug delivery reviews 2007, 59 (6), 
444-453. 
33. Chattopadhyay, P.; Huff, R.; Shekunov, B. Y., Drug encapsulation using supercritical 
fluid extraction of emulsions. Journal of pharmaceutical sciences 2006, 95 (3), 667-679. 
34. Pandey, R.; Sharma, S.; Khuller, G., Oral solid lipid nanoparticle-based antitubercular 




35. Hu, F.; Yuan, H.; Zhang, H.; Fang, M., Preparation of solid lipid nanoparticles with 
clobetasol propionate by a novel solvent diffusion method in aqueous system and 
physicochemical characterization. International Journal of Pharmaceutics 2002, 239 (1), 121-
128. 
36. Chaw, C.; Yang, Y.; Lim, I.; Phan, T., Water-soluble betamethasone-loaded poly 
(lactide-co-glycolide) hollow microparticles as a sustained release dosage form. Journal of 
microencapsulation 2003, 20 (3), 349-359. 
37. Xie, S.; Wang, S.; Zhu, L.; Wang, F.; Zhou, W., The effect of glycolic acid monomer 
ratio on the emulsifying activity of PLGA in preparation of protein-loaded SLN. Colloids and 
surfaces B: Biointerfaces 2009, 74 (1), 358-361. 
38. Gasco, M. R., Method for producing solid lipid microspheres having a narrow size 
distribution. Google Patents: 1993. 
39. Cavalli, R.; Caputo, O.; Carlotti, M. E.; Trotta, M.; Scarnecchia, C.; Gasco, M. R., 
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. 
International Journal of Pharmaceutics 1997, 148 (1), 47-54. 
40. Ugazio, E.; Cavalli, R.; Gasco, M. R., Incorporation of cyclosporin A in solid lipid 
nanoparticles (SLN). International Journal of Pharmaceutics 2002, 241 (2), 341-344. 




42. Lesmes, U.; McClements, D. J., Structure–function relationships to guide rational design 
and fabrication of particulate food delivery systems. Trends in Food Science & Technology 
2009, 20 (10), 448-457. 
43. Wooster, T. J.; Golding, M.; Sanguansri, P., Impact of oil type on nanoemulsion 
formation and Ostwald ripening stability. Langmuir 2008, 24 (22), 12758-12765. 
44. Qian, C.; Decker, E. A.; Xiao, H.; McClements, D. J., Solid Lipid Nanoparticles: Effect 
of Carrier Oil and Emulsifier Type on Phase Behavior and Physical Stability. Journal of the 
American Oil Chemists' Society 2012, 89 (1), 17-28. 
45. Freitas, C.; Müller, R. H., Effect of light and temperature on zeta potential and physical 
stability in solid lipid nanoparticle (SLN™) dispersions. International journal of pharmaceutics 
1998, 168 (2), 221-229. 
46. Pecora, R., Dynamic light scattering: applications of photon correlation spectroscopy. 
Springer-Verlag New York, LLC: 1985. 
47. Frisken, B. J., Revisiting the method of cumulants for the analysis of dynamic light-
scattering data. Applied Optics 2001, 40 (24), 4087-4091. 
48. Holthoff, H.; Egelhaaf, S. U.; Borkovec, M.; Schurtenberger, P.; Sticher, H., Coagulation 
rate measurements of colloidal particles by simultaneous static and dynamic light scattering. 




49. Lin, S. Y.; Wu, S. H.; Chen, C. h., A simple strategy for prompt visual sensing by gold 
nanoparticles: general applications of interparticle hydrogen bonds. Angewandte Chemie 
International Edition 2006, 45 (30), 4948-4951. 
50. Xu, R.; Wu, C.; Xu, H., Particle size and zeta potential of carbon black in liquid media. 
Carbon 2007, 45 (14), 2806-2809. 
51. Zimmermann, E.; Müller, R. H., Electrolyte-and pH-stabilities of aqueous solid lipid 
nanoparticle (SLN™) dispersions in artificial gastrointestinal media. European journal of 
pharmaceutics and biopharmaceutics 2001, 52 (2), 203-210. 
52. Jenning, V.; Schäfer-Korting, M.; Gohla, S., Vitamin A-loaded solid lipid nanoparticles 
for topical use: drug release properties. Journal of Controlled Release 2000, 66 (2), 115-126. 
53. Gabizon, A.; Catane, R.; Uziely, B.; Kaufman, B.; Safra, T.; Cohen, R.; Martin, F.; 
Huang, A.; Barenholz, Y., Prolonged circulation time and enhanced accumulation in malignant 
exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Research 
1994, 54 (4), 987-992. 
54. Westesen, K.; Bunjes, H., Do nanoparticles prepared from lipids solid at room 
temperature always possess a solid lipid matrix? International Journal of Pharmaceutics 1995, 
115 (1), 129-131. 
55. Markov, I. V.; Markov, I. V., Crystal growth for beginners: fundamentals of nucleation, 




56. Uner, M.; Wissing, S.; Yener, G.; Muller, R., Influence of surfactants on the physical 
stability of solid lipid nanoparticle (SLN) formulations. Die Pharmazie-An International Journal 
of Pharmaceutical Sciences 2004, 59 (4), 331-332. 
57. Bunjes, H.; Koch, M. H., Saturated phospholipids promote crystallization but slow down 
polymorphic transitions in triglyceride nanoparticles. Journal of Controlled Release 2005, 107 
(2), 229-243. 
58. Freitas, C.; Müller, R., Correlation between long-term stability of solid lipid 
nanoparticles (SLN™) and crystallinity of the lipid phase. European journal of pharmaceutics 
and biopharmaceutics 1999, 47 (2), 125-132. 
59. Helgason, T.; Awad, T.; Kristbergsson, K.; McClements, D.; Weiss, J., Influence of 
polymorphic transformations on gelation of tripalmitin solid lipid nanoparticle suspensions. 
Journal of the American Oil Chemists' Society 2008, 85 (6), 501-511. 
60. Bunjes, H.; Koch, M. H.; Westesen, K., Influence of emulsifiers on the crystallization of 
solid lipid nanoparticles. Journal of pharmaceutical sciences 2003, 92 (7), 1509-1520. 
61. Awad, T. S.; Helgason, T.; Kristbergsson, K.; Decker, E. A.; Weiss, J.; McClements, D. 
J., Effect of cooling and heating rates on polymorphic transformations and gelation of tripalmitin 
solid lipid nanoparticle (SLN) suspensions. Food Biophysics 2008, 3 (2), 155-162. 
62. Lopez, C.; Lesieur, P.; Keller, G.; Ollivon, M., Thermal and structural behavior of milk 




63. Ten Grotenhuis, E.; Van Aken, G.; Van Malssen, K.; Schenk, H., Polymorphism of milk 
fat studied by differential scanning calorimetry and real-time X-ray powder diffraction. Journal 
of the American Oil Chemists’ Society 1999, 76 (9), 1031-1039. 
64. Venkateswarlu, V.; Manjunath, K., Preparation, characterization and in vitro release 
kinetics of clozapine solid lipid nanoparticles. Journal of controlled release 2004, 95 (3), 627-
638. 
65. Miiller, R.; Lippacher, A.; Gohla, S., Solid lipid nanoparticles (SLN) as a carrier system 
for the controlled release of drugs. Handbook of pharmaceutical controlled release technology 
2000, 377. 
66. Heurtault, B.; Saulnier, P.; Pech, B.; Proust, J. E.; Benoit, J. P., A novel phase inversion-
based process for the preparation of lipid nanocarriers. Pharmaceut. Res. 2002, 19 (6), 875-880. 
67. Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C., Body distribution of camptothecin solid 
lipid nanoparticles after oral administration. Pharmaceutical research 1999, 16 (5), 751-757. 
68. Prombutara, P.; Kulwatthanasal, Y.; Supaka, N.; Sramala, I.; Chareonpornwattana, S., 
Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity. Food 
Control 2012, 24 (1), 184-190. 
69. Siekmann, B.; Westesen, K., Thermoanalysis of the recrystallization process of melt-





70. Jenning, V.; Thünemann, A. F.; Gohla, S. H., Characterisation of a novel solid lipid 
nanoparticle carrier system based on binary mixtures of liquid and solid lipids. International 
journal of pharmaceutics 2000, 199 (2), 167-177. 
71. Souto, E.; Wissing, S.; Barbosa, C.; Müller, R., Development of a controlled release 
formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of 
Pharmaceutics 2004, 278 (1), 71-77. 
72. Jenning, V.; Mäder, K.; Gohla, S. H., Solid lipid nanoparticles (SLN™) based on binary 
mixtures of liquid and solid lipids: a1 H-NMR study. International journal of pharmaceutics 
2000, 205 (1), 15-21. 
73. Cortesi, R.; Esposito, E.; Luca, G.; Nastruzzi, C., Production of lipospheres as carriers for 
bioactive compounds. Biomaterials 2002, 23 (11), 2283-2294. 
74. Helgason, T.; Awad, T. S.; Kristbergsson, K.; Decker, E. A.; McClements, D. J.; Weiss, 
J., Impact of surfactant properties on oxidative stability of β-carotene encapsulated within solid 
lipid nanoparticles. Journal of Agricultural and Food Chemistry 2009, 57 (17), 8033-8040. 
75. Xie, S.; Wang, S.; Zhao, B.; Han, C.; Wang, M.; Zhou, W., Effect of PLGA as a 
polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. 
Colloids and surfaces B: Biointerfaces 2008, 67 (2), 199-204. 
76. Jores, K.; Mehnert, W.; Drechsler, M.; Bunjes, H.; Johann, C.; Mäder, K., Investigations 




photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. 
Journal of Controlled Release 2004, 95 (2), 217-227. 
77. Müller, R.; Maassen, S.; Schwarz, C., Solid lipid nanoparticles (SLN) as potential carrier 
for human use: interaction with human granulocytes. Journal of Controlled Release 1997, 47 (3), 
261-269. 
78. Lobovkina, T.; Jacobson, G. B.; Gonzalez-Gonzalez, E.; Hickerson, R. P.; Leake, D.; 
Kaspar, R. L.; Contag, C. H.; Zare, R. N., In vivo sustained release of siRNA from solid lipid 
nanoparticles. ACS nano 2011, 5 (12), 9977-9983. 
79. Zara, G. P.; Bargoni, A.; Cavalli, R.; Fundarò, A.; Vighetto, D.; Gasco, M. R., 
Pharmacokinetics and tissue distribution of idarubicin‐loaded solid lipid nanoparticles after 
duodenal administration to rats. Journal of pharmaceutical sciences 2002, 91 (5), 1324-1333. 
80. Cavalli, R.; Bocca, C.; Miglietta, A.; Caputo, O.; Gasco, M., Albumin adsorption on 
stealth and non-stealth solid lipid nanoparticles. STP pharma sciences 1999, 9 (2), 183-189. 
81. Bocca, C.; Caputo, O.; Cavalli, R.; Gabriel, L.; Miglietta, A.; Gasco, M. R., Phagocytic 
uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. International journal of 
pharmaceutics 1998, 175 (2), 185-193. 
82. Fundarò, A.; Cavalli, R.; Bargoni, A.; Vighetto, D.; Zara, G. P.; Gasco, M. R., Non-
stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and 





83. Ugazio, E.; Cavalli, R.; Gasco, M. R., Incorporation of cyclosporin A in solid lipid 
nanoparticles (SLN). Int. J. Pharm. 2002, 241 (2), 341-344. 
84. Fathi, M.; Varshosaz, J.; Mohebbi, M.; Shahidi, F., Hesperetin-loaded solid lipid 
nanoparticles and nanostructure lipid carriers for food fortification: preparation, characterization, 
and modeling. Food and Bioprocess Technology 2012, 1-12. 
85. Triplett II, M. D.; Rathman, J. F., Optimization of β-carotene loaded solid lipid 
nanoparticles preparation using a high shear homogenization technique. Journal of Nanoparticle 
Research 2009, 11 (3), 601-614. 
86. Carlotti, M.; Sapino, S.; Trotta, M.; Battaglia, L.; Vione, D.; Pelizzetti, E., Photostability 
and stability over time of retinyl palmitate in an O/W emulsion and in SLN introduced in the 
emulsion. Journal of dispersion science and technology 2005, 26 (2), 125-138. 
87. Sapino, S.; Carlotti, M.; Pelizzetti, E.; Vione, D.; Trotta, M.; Battaglia, L., Protective 
effect of SLNs encapsulation on the photodegradation and thermal degradation of retinyl 











































Stearic acid High pressure 
homogenization 
67 
Doxorubicin Epikuron 200* Stearic acid Microemulsion 82 




72, 39,  37 
Retinoic acid Soy lecithin, 
Tween 80* 
Campritol 888* High pressure 
homogenization 
36 





Table 1.1. Continued. 
Incorporated 
drug 






















































Table 1.1. Continued. 
Incorporated 
drug 













Hesperetin Tween 80* Glycerol monostearate, 
stearic acid 
Sonication 84 




Softisan 378*, Softisan 
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Table 1.1. Continued. 
*Chemical structures of corresponding commercial names. 
Poloxamer 188: poly (ethylene glycol)-block-poly (propylene glycol)-block-poly(ethylene 
glycol). 
Campritol 888 ATO:  Cetyl palmitate, glyceryl behenate. 
Epikuron 200: soya phosphatidylcholine. 
Miglyol 812: caprylic/ capric Triglyceride. 
Tween 80: polyoxyethylene (20) sorbitan monooleate. 
Tween 60: polyoxyethylene (20) sorbitan monostearate. 
Softisan 378: a blend of triglycerides based on saturated even-numbered, unbranched natural 
fatty acids of vegetable origin with a chain length of C8 – C18. 
Softisan 154: a blend of triglycerides based on saturated even-numbered, unbranched natural 
fatty acids of vegetable origin with a chain length of C14 – C18. 








Figure 1.1. Comparison of a liquid nanoemulsion (left) and solid lipid nanoparticles (right) with 






Figure 1.2. Common procedures in melt and cold homogenization approaches used to prepare 






Figure 1.3. Processes used to prepare SLNs by supercritical extraction of emulsion. Adapted 






Figure 1.4. Comparison of differential scanning calorimetry patterns of bulk triglycerides and 
the corresonding nanodispersion during cooling at various rates. Green, red and blue curves 
represented cooling at 0.2 °C/min, 2.0 °C/min, and 20 °C/min respectively. The figure is adapted 






Figure 1.5. Correlations between hexagonal, cubic, and orthogonal arranges of triaglycerides, x-
ray scattering patterns, and α, β′, and β-crystal polymorphisms. Adapted from Westesen, Bunjes, 






Figure 1.6. Three models showing the distribution of active compounds in SLNs: Homogeneous 













This chapter is a lightly revised version of a paper by the same title submitted to the Journal of 
Agricultural and Food Chemistry by Linhan Zhang, Douglas G. Hayes, Guoxun Chen and Qixin 
Zhong. The use of “our” in this chapter refers to my co-authors and I. My primary contributions 
to this paper include (1) the preparation of sample, (2) the data collection and analysis, (3) the 












Solid lipid nanoparticles (SLNs) are possible vehicles to incorporate lipophilic bioactive 
compounds in transparent functional beverages. In this work, AMF and Tween 80 were used to 
prepare SLNs by using a phase inversion temperature method, and beta-carotene was used as a 
model lipophilic bioactive compound. The phase inversion temperature decreased from >95 C 
to 73 C, when NaCl was increased from 0 to 1.0 M in the aqueous phase. At 0.8 M NaCl and 
phase inversion by heating at 90 C for 30 min, transparent SLNs dispersions were observed at 
AMF level higher than 10% w/w, corresponding to particles smaller than ~25 nm. The SLNs 
dispersions were dilution and dialysis stable and maintained turbidity level and particle size 
during 90-day storage at room temperature. The degradation of beta-carotene encapsulated in 
SLNs was much reduced when compared with its encapsulation in the soybean oil-based 
nanoemulsion.  
 
Keywords: Solid lipid nanoparticles, phase inversion temperature method, anhydrous milk fat, 





There are numerous lipophilic bioactive compounds of significance to food, 
pharmaceutical, and other consumer products 1. However, low solubility and poor stability are 
two major concerns when incorporating these bioactive compounds in products that possess an 
aqueous continuous phase. Thus, a suitable delivery system is needed to physically distribute 
them in product matrices with maintained chemical stability during storage, either in the 
presence or absence of hydrophilic and lipophilic antioxidant compounds 2. 
The lipid core of oil-in-water (O/W) emulsions is commonly used to encapsulate 
lipophilic bioactive compounds. Furthermore, nanoemulsions, with droplet diameters smaller 
than about 200 nm, have the advantages of good physical stability during storage and a 
translucent or even transparent appearance 3-4. Nanoemulsions have also shown the enhanced 
bioavailability of encapsulated bioactive compounds like beta-carotene 5. If the oil body of 
nanoemulsions can be prepared from lipids present in the solid state at typical application 
conditions, so-called solid lipid nanoparticles (SLNs), the degradation of encapsulated bioactive 
compounds can be much reduced 6. This is because the solid lipid matrix reduces the mobility of 
encapsulated compounds diffusing to the particle surface where most of degradation occurs 6. A 
variety of SLN systems have been developed as effective delivery agents 7-9. But much work is 
needed to fabricate transparent SLN dispersions using low-cost and scalable processes. 
SLNs are usually formed by high energy methods such as high pressure homogenization 
above or below the melting temperature of lipids 8, 10-11. High energy methods are effective in 
reducing particle size but demand high capital and operating costs. Degradation of sensitive 
compounds during processing is another concern. Conversely, low energy methods such as those 




specialized equipment and high mechanical energy 3. In particular, the phase-inversion 
temperature (PIT) method has been used to prepare transparent nanoemulsions of lemon oil 12. 
Since heating lipids above the melting temperature is needed to dissolve lipophilic compounds 
before preparing SLNs, it is logical to form transparent SLN dispersions using the PIT method, 
which has not been studied. 
The phase behavior of water-oil-surfactant systems as a function of surfactant properties, 
temperature, and composition is affectively described by the hydrophilic lipophilic 
deviation(HLD, eq 1 for nonionic surfactants) 13.  
HLD = α - EON – k ACN + b S + Φ(A) + CT (T - Tref)   (1) 
Negative and positive HLD values indicate the possibility of forming O/W and W/O type 
emulsions, respectively, while a bicontinuous phase behavior corresponds to a HLD value of 0 
14. For an emulsion with a fixed composition, a fine emulsion with small particle size can be 
formed during the process of inversion between W/O and O/W emulsions due to changes in 
temperature 15-16. Partial inversion was observed for transformation of turbid coarse O/W 
emulsions of lemon oil emulsified by Tween 80 (polyoxyethylene (20) sorbitan monooleate)  to 
transparent nanoemulsions after heating at 90 C for 30 min 12. 
where α is a characteristic parameter of the lipophilic part of the surfactant; EON is the number 
of ethylene oxide groups per surfactant molecular, ACN is the number of carbon atoms in the 
alkyl tail of molecule (or equivalent); Φ(A) is a function of the alcohol (added as a co-surfactant)  
type and concentration; S is the salinity of the aqueous phase in wt% of NaCl or equivalent salt; 
T is the temperature (°C); Tref is generally taken at 25 °C; and k, b, and CT are constants 
characteristic of the surfactant type and electrolyte 13. The value of temperature coefficient CT is 




The first objective of this work was to study the formation of transparent dispersions of 
SLNs using the PIT method. AMF was chosen as the solid lipid because it is a commercially 
available dairy ingredient. Variables in SLN formation were studied for thermal treatment 
conditions, salinity, and composition. The second objective was to study the prevention of 
degradation for beta-carotene, a model lipophilic bioactive compound, when encapsulated in 
SLNs. 
2. Materials and Methods 
2.1. Materials 
AMF was kindly donated by Land O'Lakes, Inc. (St. Paul, MN). Polyoxyethylene (20) 
sorbitan monooleate (Tween 80), NaCl (purity >99.5%), ethanol, hexane, and deionized water 
were purchased from Fisher Scientific (Pittsburgh, PA). Soybean oil was a product of Kroger Co. 
(Cincinnati, OH). Beta-carotene (predominantly in the trans form) was purchased from MP 
Biomedicals, LLC (Solon, OH). Potassium persulfate, 6-hydroxy-2, 5, 7, 8-tet-ramethychroman-
2-carboxylic acid (Trolox), and 2, 2’-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) 
diammonium salt (ABTS) were products of Sigma-Aldrich Corp. (St. Louis, MO). 
2.2. Preparation of SLNs dispersions 
2.2.1. Preparation of surfactant solutions 
NaCl and Tween 80 were dissolved in deionized water at concentrations of 0-1.00 M and 
5-40% w/w respectively. The mixtures were stirred overnight to ensure complete dissolution and 




2.2.2. Preparation of coarse emulsions 
Preparation of coarse emulsions and SLN nanodispersions was investigated based on a 
PIT method detailed previously 12, with some modifications. To form a coarse emulsion, AMF 
was heated to 60 ℃ for complete melting, followed by mixing with warm (60 C) aqueous phase 
under agitation at 1000 rpm using a magnetic stirring plate. The AMF concentration in coarse 
emulsions was 1-15% w/w. For encapsulation studies, beta-carotene was dissolved in warm 
AMF at a concentration of 6.25 mM before emulsification. To compare impacts of the structure 
of lipid body (solid fat vs. liquid oil) on the stability of encapsulated beta-carotene, a control 
nanoemulsion was prepared using soybean oil at conditions comparable to the treatment using 
AMF. 
2.2.3. Thermal treatment for preparation of SLNs 
The coarse emulsions were transferred to 4 mL glass vials that were heated for 30 min in 
a water bath maintained at a constant temperature (75, 80, 85, 90, or 95 ℃) without stirring. 
After thermal treatment, these samples were first cooled at ambient conditions with hand shaking 
till a homogenous appearance, followed by quenching in an ice bath under static conditions. 
2.3. Turbidity measurement 
Turbidity of samples was measured for absorbance at 600 nm (Abs600) using a UV/vis 
spectrophotometer (Unicam, Cambridge, UK). Tween 80 solutions at corresponding 
concentrations were used as controls. 
2.4. Particle size determination 
The particle size of samples was measured by using a DelasTM Nano particle analyzer 




diluted to an appropriate concentration in deionized water prior to analysis. The volume-length 
mean diameter was calculated as following: 
d4,3 = ∑ni di
4/∑ni di
3      (2) 
where ni and di are the number and diameter of the i
th group of particles.  
2.5. Viscosity measurement 
Rheological properties of dispersions were studied with an AR 2000 rheometer (TA 
Instrument, New Castle, DE) using a Searle setup (bob outer diameter = 28 mm and cup inner 
diameter = 30 mm). After loading the sample, heating to and equilibrated at 95 ℃ for 2 min, a 
temperature sweep with a fixed shear rate of 100 s-1 13 was applied from 95 to 25 ℃ at 3 ℃/min. 
A thin layer of soybean oil was applied on the top of sample to minimize water evaporation. 
2.6. Differential scanning calorimetry (DSC) 
DSC (model Q2000, TA Instruments, New Castle, DE) was used to study melting and 
crystallization properties of AMF and SLNs during heating and cooling. The transparent SLN 
dispersion prepared with 15% AMF and 45% Tween 80 in 0.8 M NaCl as the aqueous phase was 
used to generate detectable endothermic and exothermic peaks. A sample corresponding to 5-8 
mg AMF or 15-20 mg SLN dispersion was placed in an aluminum pan and hermetically sealed. 
An empty pan was used as a reference. The thermal profile was studied by two cycles, with each 
cycle following the steps of holding at -15 C for 5 min, heating from -15 to 90 ℃ at 5 ℃/min 





2.7. Atomic force microscopy (AFM) 
The shape and dimension of particles were characterized using a NanoScope IIIA 
Multimode AFM (Veeco Instruments Inc., Santa Barbara, CA). The SLN dispersion was first 
diluted to 10 ppm of AMF using deionized water. Two µL of the diluted sample was dropped on 
a freshly cleaved mica disk and dried under ambient temperature (21 C) overnight. A resonant 
frequency of about 71.0 kHz and a scan rate of 1.0 Hz were applied. Images were collected at the 
tapping mode and analyzed using the instrument software. 
2.8. X-ray diffraction (XRD) 
Crystallinity of pristine beta-carotene, AMF and beta-carotene-loaded SLNs was studied 
by XRD (Panalyticla, Westborough, MA). SLN dispersions were freeze-dried before being 
spread on the glass plate and pressed to make a smooth layer. The diffraction spectrum was 
acquired at 2°/min for a 2θ range of 5-55°. The Cu KR radiation (λ = 1.54 Å) was generated at 
30 kV and 10 mA.  
2.9. Antioxidant properties 
The antioxidant properties of the emulsions were estimated using an ABTS method 18-19. 
This method measures the relative ability of antioxidant substances to scavenge the ABTS+, 
which is referenced to Trolox, an antioxidant standard. To generate ABTS+, 7 mM ABTS and 
2.45 mM potassium persulfate were dissolved in ethanol and allowed to stand in the dark at room 
temperature overnight. The ABTS+ solution was diluted with ethanol to an absorbance of 0.70 
(±0.02) at 734 nm. Two µL of Trolox or emulsion was mixed with 2 mL of the ABTS+ solution, 
and the absorbance of the mixture at 734 nm was measured after mixing for 15 min. The 




concentration of Trolox and emulsion. The antioxidant properties were obtained by referring to a 
standard curve established from Trolox and expressed as mM Trolox equivalents per mL. 
2.10. Quantification of beta-carotene concentration 
Beta-carotene concentration in the emulsion was determined using absorbance 20. Twenty 
µL of an emulsion sample was extracted by using a mixture composed of 2 mL ethanol and 3 mL 
hexane. After hand shaking for 2 min, the upper organic phase was collected. The remainder 
aqueous phase was extracted repeatedly until the top phase became colorless. All hexane extracts 
were pooled into a 10 mL flask and added with hexane to a total volume of 10 mL. The 
absorbance at 450 nm was measured using a UV-Visible spectrophotometer (Unicam, 
Cambridge, UK). The concentrations of beta-carotene in emulsions were obtained by referring to 
a standard curve established from standard solutions with different amounts of beta-carotene in 
hexane.  
2.11. Storage stability of SLNs and encapsulated beta-carotene 
Physical stability of SLNs 
Selected SLN dispersions without beta-carotene and the corresponding dispersions after 
dialysis treatment were stored for 90 days at ambient temperature (21 C). The dialysis of NaCl-
containing emulsions was conducted using a membrane with a molecular weight cut-off of 3500 
Da (Fisher brand, Pittsburgh, PA) which was immersed in bulk distilled water for 48 h that was 
exchanged with fresh water every 6 h. Two mL dispersions were included in 4 mL capped glass 
vials, and the Abs600 and particle size in individual vials were measured periodically using the 
methods described above.  




The stability of beta-carotene in SLNs and comparable nanoemulsions prepared with 
soybean oil was characterized for changes of both antioxidant properties and beta-carotene 
content during room temperature (21 C) storage for 16 days. Samples in 4 mL sealed clear glass 
vials were exposed to LED fluorescent light during storage. Individual vials were sampled every 
two days for assays of beta-carotene concentration and antioxidant property as above. 
Antioxidant properties of SLNs and soybean oil nanoemulsions without beta-carotene were also 
determined and used as controls.  
2.12. Statistical analysis 
All samples were prepared in duplicate. All measurements were repeated at least twice. 
Results from all measurements were reported for means and standard deviations. Significant 
differences were analyzed with a least-significant-difference (P < 0.05) mean separation method, 
assisted by using Statistical Analysis Software (V9.2, SAS Institute, Cary, NC). 
 
3. Results and Discussion 
3.1. Influence of salinity and temperature on SLNs formation 
The first group of experiments was used to study temperature and NaCl concentration 
that are important parameters of HLD (eq 1). Furthermore, based on our preliminary trials, 
emulsions with high surfactant concentrations can form gels at high NaCl concentrations during 
thermal treatments, while a low surfactant-to-oil ratio (SOR) typically results in phase 
separation. Therefore, this group of samples was prepared with 1% w/w AMF and aqueous phase 
with 15% w/w Tween 80 and 0-1.0 M NaCl. After heating at 80-95 C for 30 min and cooling to 




than 0.4 M had no significant change in Abs600 after heating, while those containing 0.6-1.0 M 
NaCl showed significant reduction in Abs600 at a heating temperature of 85-95 C. Figure 2.1 
also indicates that a lower NaCl concentration was required to transform turbid emulsions to 
transparent ones when heated at 95 C than at 90 C. 
Figure 2.1 suggests that temperature and NaCl concentration strongly control phase inversion. 
Monitoring viscosity changes of emulsions during cooling is a convenient method to characterize 
phase behavior and determine the PIT 21-22. Figure 2.2 shows viscosities of samples during 
cooling from 95 to 35 C and the determined PIT. Using the emulsion formed from 0.80 M NaCl 
as an example, the sample viscosity was small at high temperatures. When the temperature 
decreased to about 77 ℃, the viscosity increased quickly and reached a maximum value at 65 C. 
Upon further cooling, viscosity decreased until reaching about 55 ℃, followed by an increase 
with a further decrease in temperature. Typically, there are two viscosity maxima during cooling, 
corresponding to formation of fine W/O and O/W emulsions, and the temperature corresponding 
to the lowest viscosity between the two maxima is treated as the PIT 21. For systems with a large 
water fraction (fw) as the case of the present study, the viscosity maximum above the PIT is 
usually not observed 13, possibly due to the formation of multiple W/O/W emulsions instead of 
W/O ones. The PIT of systems with high water content can be approximated by the temperature 
at which the viscosity starts to increase during cooling, e.g., 76 ℃ for the system containing 0.8 
M NaCl. As presented in Figure 2.2, emulsions containing a higher NaCl concentration had a 
lower PIT. According to eq (1), HLD is larger at a higher NaCl concentration, requiring a lower 
temperature (PIT) to reach an HLD value of zero, i.e. phase inversion. The remaining 
experiments to form SLNs were conducted at NaCl concentration of 0.8 M and thermal treatment 




3.2. Influence of surfactant: oil ratio on SLNs formation 
The impact of composition on SLN formation was studied for emulsions with 1.0-15.0% 
w/w AMF in the aqueous phase with 10.0-40.0% w/w Tween 80 and 0.80 M NaCl. Samples with 
low oil concentrations were transparent before heating (1, 1-3, and 1-7% w/w AMF for the 
treatments with 20, 30, and 40% w/w Tween 80 in the aqueous phase, respectively), because 
micelles of Tween 80 are capable of dissolving some lipids, forming O/W microemulsions. 
These samples remained transparent and had low Abs600 after thermal treatment. Turbid 
emulsions with 2-6, 4-10, and 8-14% w/w AMF in samples with 20, 30, and 40% Tween 80 in 
the aqueous phase, respectively, became transparent after thermal treatment, while turbid 
emulsions were still observed after heating samples with higher AMF concentrations. Some 
samples with high AMF concentrations even underwent phase separation, with creaming 
observed after 10 min. These observations are demonstrated visually in Figure 2.3A for 
emulsions with 30% w/w Tween 80 in the aqueous phase. Consistent with these observations, 
values of Abs600 and d4,3 of samples after cooling to room temperature are shown in Figure 2.4A 
and 2.4B, respectively. Generally, transparent samples are evidenced by small Abs600 (<0.1 
absorbance units) and d4,3 (< ~ 23 nm) because of the inability of small SLNs in scattering visible 
light. All samples with the lowest amount of Tween 80 (10% w/w in the aqueous phase) were 
turbid before and after heating. Sub-micrometer sized particles (<400 nm) were observed for 
samples with 8-10, 12-15, and 15% w/w AMF in the aqueous phase with 20, 30, and 40% w/w 
Tween 80, respectively. The standard deviations of d4,3 and widths of size distributions (the latter 
not shown) were large for these treatments, possibly because of the deficiency of surfactants 




role. Conditions enabling formation of SLNs are summarized in Figure 3B for this group of 
treatments, in the form of a phase diagram. 
Our results generally agreed with those of Rao and McClements 12. In their research, 
propylene glycol was used in the aqueous phase to enhance the inversion of transparent 
nanoemulsions with lemon oil. In contrast, propylene glycol was not observed to enhance the 
formation of transparent SLN dispersions in our preliminary studies. This may be due to the 
lower solubility and higher melting temperature of AMF than those of lemon oil. 
It is worth noting that the stability of surfactant-based systems upon dilution is an 
important attribute. For the systems with lemon oil emulsified with Tween 80 12, samples 
containing relatively high surfactant concentrations after thermal treatment exhibited increased 
turbidity after dilution. The observations were attributed to the instability of microemulsion 
subjected to compositional changes. In the present study, all transparent samples remained stable 
upon dilution at room temperature. The differences between the two studies perhaps are related 
to the interface of lemon oil/water being more fluidic, while the interface between solid lipid 
core and water is more rigid in our study. Droplets composed of solid lipids also are less 
susceptible to emulsion instability mechanisms such as coalescence and Ostwald ripening. The 
structure and storage stability of SLNs are presented in following sections using emulsions 
prepared with 10% w/w AMF and an aqueous phase with 30% w/w Tween 80 in 0.8 M NaCl, 
after heating at 90 C for 30 min. 
3.3. Structure of SLNs studied by AFM and XRD 
3.3.1 AFM 
Figure 2.5A displays an AFM image of SLNs in a transparent dispersion. Particles were 




heights measured by AFM (<5 nm, Figure 2.5B) were much smaller, as reported in other studies 
23-25. The difference may be due to the underlying theory for the two methods. An assumption 
used in dynamic light scattering (DLS), “infinite dilution” 26, is hard to fulfill. If interactions 
among particles occur, common for emulsion systems, the interaction may contribute toward the 
diffusion coefficients obtained from DLS. Thus, the estimation of particle size obtained by the 
Stokes-Einstein Equation may be overestimated. Additionally, the dimension occupied by 
particles may decrease after drying the SLN dispersion for AFM. 
3.3.2 XRD 
XRD is a convenient technique not only for characterizing SLNs 27-28 but also for 
confirming the encapsulation of lipophilic compounds 29, especially beta-carotene, which is 
highly crystalline 30-31. AMF also has crystalline structures below its melting temperature 32. 
Because AMF is composed of a mixture of lipids, its crystalline structures are dependent on 
temperature and cooling rate 33-34. Figure 2.6 shows the XRD spectra of beta-carotene, AMF, and 
beta-carotene-loaded SLNs. Beta-carotene showed several sharp peaks, indicating crystallinity, 
while AMF possesses smaller and broader peaks, indicating that AMF has mixed morphology at 
room temperature. It has previously been suggested that amorphous morphology is dominant, but 
crystalline structure is also present in AMF at room temperature 35. For SLNs loaded with beta-
carotene, because Tween 80 is a non-crystalline compound at ~20 C36-38, the smooth XRD curve 
of the beta-carotene-loaded SLNs and its similarity to the spectrum of AMF suggest that beta-
carotene was embedded in SLNs 39. Detailed structures of AMF crystals however were not 





Thermograms of AMF and SLNs during heating and cooling cycles are shown in Figure 
2.7. During heating, multiple melting temperatures of AMF were observed at about 8.7, 15.3, 
and 24.1 C, with the last peak extending to 36.4 C. During the subsequent cooling process, the 
crystal formation started at around 17.6 ℃ and the crystalline process of mostly oil happened 
around 5.0 °C. The two cycles of heating-cooling process do not showed any differences, 
indicating bulk recrystallization of AMF would not affect its crystal type and melting 
temperature. The DSC results of AMF agree with previous studies 43-44. Multiple melting 
temperatures suggested in Figure 2.7 are due to the fact that AMF is a mixture of triglycerides 
containing more than 400 fatty acids, both saturated and unsaturated, including oleic acid, 
palmitic acid, myristic acid, and stearic acid 45. First cycle of heating curves of SLN showed a 
strong endothermic peak at 15.3 °C. While the other two melting peak showed in the heating 
curved of bulk AMF do not present as obvious as in the heating curve of SLN. In the subsequent 
cooling cycle of SLN, initial crystal formation temperature is the same as bulk AMF. But the 
main exothermic peak happened around -3.2 °C, much lower than bulk AMF.  The differences of 
crystallization behavior of lipids in SLN agrees with previous study that the solidification 
temperature of lipid core in SLN may be lower than that of bulk lipids46. Lipids may exist as 
super-cooled melts in SLN47. The differences between first and second cycle of SLN may due to 
particle coalescence or free oil in the SLN48-49. Thus, AMF in SLN dispersion is present as a 
mixture of solid state and liquid state at room temperature (21 C) in the present study. The DSC 
(Figure 2.7) and XRD (Figure 2.6) results suggest that AMF in SLNs does not have extensive 




nanostructured lipid carriers that are advantageous in encapsulation when compared to SLNs 
with highly ordered crystals. 11 
3.4. Physical storage stability of SLNs 
Figure 2.8 contains Abs600 and d4,3 values of emulsions, stored at room temperature (21 
°C) for 90 days, for SLN dispersions with and without dialysis. The initial d4,3 and Abs600 of the 
emulsion with NaCl were 25.5 ± 3.0 nm and 0.13 ± 0.02, respectively. During the storage, there 
was no significant changes in the Abs600 and d4, 3 (P > 0.05), which were 25.4 ± 1.3 nm and 0.10 
± 0.00, respectively, at the end of the storage. Furthermore, dialysis did not change Abs600 and d4, 
3 of samples and their stability during storage. Therefore, the AMF-based SLN dispersions 
possess excellent physical stability during storage, which again can be attributed to the 
elimination of coalescence and Ostwald ripening due to use of solid phase lipids as the dispersed 
phase. 
3.5. Stability of beta-carotene during storage 
Figure 2.9 shows changes in antioxidant potential and concentration of beta-carotene 
loaded in SLNs during 16-day storage at room temperature (21 C). To study the influence of 
physical structures of lipid droplets on the stability of loaded bioactive compounds, an emulsion 
control was prepared by substituting AMF with soybean oil that has a similar average fatty acid 
chain length as AMF. The d4,3 of soybean oil nanoemulsion (29.8 ± 0.0 nm) was comparable 
with that of SLNs and was stable after 16 day-storage (30.3 ± 1.0 nm). The net antioxidant 
potential of beta-carotene in nanoemulsions was determined by subtracting the measured 
potential of the corresponding nanoemulsion without beta-carotene. Both net antioxidant 




carotene encapsulated in SLN treatment showed much slower degradation than its encapsulation 
with soybean oil. By the end of storage, about 94.8% loss of the beta-carotene concentration and 
97.4% loss of net antioxidant potential were observed for the latter system. In contrast, the 
concentration and net antioxidant potential of beta-carotene encapsulated in SLNs only 
decreased by 47.3% and 66.7%, respectively. The concentration change of encapsulated beta-
carotene (Figure 2.9B) followed the first order kinetics, as reported previously for beta-carotene 
in safflower seed oil 50. The results indicate the effectiveness of SLNs in reducing the 
degradation of encapsulated bioactive compounds during storage. 
To prove the reduced degradation in SLNs is due to the lowered mobility in the solid 
lipid phase, 0.0125 mM beta-carotene was dissolved in soybean oil or AMF and stored at 65 °C 
and room temperature (21 °C) for 16 days, and the absorbance at 450 nm was measured to 
monitor changes in beta-carotene content, with the corresponding lipids as a control. Beta-
carotene degraded much faster in melted AMF (79.0 %) than in soybean oil (28.9%) at 65 °C, 
suggesting soybean oil having better antioxidant properties. At 21 °C, beta-carotene did not show 
obvious degradation in both lipids. Since soybean oil has better antioxidant properties, it 
suggests that the amorphous solid state of AMF reduces the mobility of molecules and free 
radicals to reach similar stability as beta-carotene in soybean oil. The degradation tests in bulk 
lipids further support the conclusion that the enhanced stability of beta-carotene in SLNs is due 
to the amorphous solid state of AMF. 
In summary, the present study demonstrated the feasibility to prepare transparent 
dispersions of SLNs composed of AMF as the solid lipid dispersed phase and Tween 80 as a 
nonionic surfactant by using the PIT method. Thermal treatment conditions, salinity, and 




emulsions into transparent ones after heating. An increase of salinity lowered the PIT, thus 
favoring the formation of transparent SLN dispersions. A higher surfactant concentration enabled 
the incorporation of a higher amount of AMF in transparent SLN dispersions. SLN dispersions 
remained stable upon dilution and showed practically no changes in particle size and turbidity 
during storage for 90 days at 21 °C. Beta-carotene was successfully encapsulated in SLNs using 
the PIT method and had much better stability in SLNs than in soybean oil-based nanoemulsions. 
Therefore, the simple PIT method and AMF can be used to form stable and transparent SLN 
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Figure 2.1. Absorbance at 600 nm (Abs600) of dispersions containing 1% w/w AMF and aqueous 
phase with 15% w/w Tween 80 dissolved in 0-1.0 M NaCl solutions after heating at a 
temperature between 80 and 95 C for 30 min and cooling to room temperature. Error bars are 






Figure 2.2A. The change of viscosity during cooling from 95 to 35 ℃ for an emulsion. The 
phase inversion temperature (PIT) was determined from the local minimum, as depicted. As 
shown in the inset, cooling results in the conversion of a W/O/W emulsion to an O/W emulsion. 
The emulsion contained 1% w/w anhydrous milk fat (water fraction fw =0.99) and an aqueous 
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Figure 2.2B. Effects of NaCl concentration on the viscosity of emulsions during cooling from 95 
to 35 ℃. Emulsions contained 1% w/w AMF and an aqueous phase with 15% w/w Tween 80 
dissolved in 0-1.0 M NaCl solutions. Values of the phase inversion temperature (PIT), obtained 






Figure 2.3. Appearance of emulsions before (top) and after (bottom) heating at 90 C for 30 min. 
Emulsions before heating were prepared with 1.0-15.0% w/w AMF and an aqueous phase with 
30% w/w Tween 80 dissolved in a 0.8 M NaCl solution. AMF concentration increased by 1% 






Figure 2.4. Partial phase diagram showing conditions (×100%w/w for each constituent) of 
forming microemulsions (red squares), transparent SLNs dispersions (green circles) and turbid or 
phase-separated emulsions (blue triangles) at 25 C formed by the phase inversion temperature 
method. Coarse emulsions were prepared by mixing 1-15% w/w AMF with an aqueous phase 
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Figure 2.5. Absorbance at 600 nm (Abs600) of emulsions after heating at 90 C for 30 min and 
cooling to room temperature. Emulsions were prepared with 1.0-15.0% w/w AMF and an 
aqueous phase with 10-40% w/w Tween 80 dissolved in a 0.8 M NaCl solution. Error bars are 


























Figure 2.6. Volume-length mean diameter (d4,3) of emulsions after heating at 90 C for 30 min 
and cooling to room temperature. Emulsions were prepared with 1.0-15.0% w/w AMF and an 
aqueous phase with 10-40% w/w Tween 80 dissolved in a 0.8 M NaCl solution. Samples that 
exhibited creaming within 10 min after thermal treatment are not plotted. Error bars are standard 





Figure 2.7. Atomic force microscopy topographic image with a dimension of 2 × 2 µm (A) and 
height distribution of particles along the measurement line (B). Particle size distribution of SLNs 
from light scattering is plotted in (C) for comparison. The SLNs were prepared by heating at 90 
C for 30 min using an emulsion prepared with 10% w/w AMF in an aqueous phase with 30% 























































































Figure 2.8. XRD patterns of pristine beta-carotene (blue), AMF (red) and beta-carotene-loaded 
SLNs (black). SLNs were prepared by heating at 90 C for 30 min using an emulsion prepared 
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Figure 2.9. Thermograms of AMF, SLNs during two cycles of (A) heating from -15 to 90 ℃ at 
















































Figure 2.10. Changes of (A) volume-length mean diameter (d4,3) and (B) absorbance at 600 nm 
(Abs600) of SLNs dispersions, with and without dialysis, during 90-day storage at room 
temperature (21 C). SLNs prepared by heating at 90 C for 30 min using an emulsion prepared 
with 10% w/w AMF in an aqueous phase with 30% w/w Tween 80 dissolved in a 0.8 M NaCl 







































Figure 2.11. Changes of antioxidant properties of beta-carotene-loaded SLNs dispersions during 
storage at room temperature (21 C), in comparison to a control with beta-carotene encapsulated 












































Figure 2.12. Concentration changes, in natural logarithm values, of beta-carotene loaded in 
SLNs dispersions, in comparison to a control of beta-carotene encapsulated in vegetable oil-






SLNs are nanoparticles that contain a solid lipid core and have potential applications in 
the food industry. Many approaches used to prepare conventional nanoemulsions can be used to 
prepare SLNs, including high energy and low energy methods. High energy methods include hot 
and cold HPH methods, high shear homogenization and ultrasonication methods, while solvent 
evaporation is a low energy method. SLNs can also be prepared from self-assembled 
microemulsions. The degradation of bioactives during sample preparation and possible organic 
solvent residues are concerns for food applications.  
The degradation and release of bioactives incorporated in SLNs mainly depend on the 
exact structure of SLNs with regard to the spatial distributions of the bioactives and carrier 
lipids. Burst release and faster degradation of bioactives are commonly observed when the 
encapsulated compound is mostly present in the outer shell. The prolonged release and improved 
stability of bioactives correspond to situations where bioactives are rich in the lipid core or 
distributed evenly in the SLNs.  
In this thesis, a phase inversion temperature method was used to prepared milk fat-based 
SLNs. This method only required a thermal treatment to cause phase inversion of the system. 
AMF is a mixture of more than 40 kinds of lipids with different chain lengths. The impurity of 
lipids can benefit the formation of less perfect crystals, or even amorphous solids. This kind of 
structure would increase the loading of bioactives in SLNs and thus avoid the burst release. A 
mixture of different lipids can also increase physical stability of SLNs by preventing crystal 




prepare the system. NaCl was added to the system to lower the PIT and therefore facilitate phase 
inversion.  
Thermal treatment conditions, salinity, and surfactant-to-oil ratio all played important 
roles in the effectiveness of transforming turbid emulsions into transparent ones after heating. An 
increase of salinity lowered the PIT, thus favoring the formation of transparent SLN dispersions. 
A higher surfactant concentration enabled the incorporation of a higher amount of AMF in 
transparent SLN dispersions. The prepared transparent SLNs have relatively small particle 
diameters (23 nm). SLN dispersions remained stable upon dilution and had consistent particle 
size and turbidity during 90 day storage at room temperature. 
Beta-carotene was used as a model lipophilic bioactive compound. Compared with 
soybean oil-based nanoemulsions, beta-carotene showed a much longer storage stability in terms 
of residual concentrations and antioxidant properties. Therefore, the simple PIT method and 
AMF can be used to form stable and transparent SLN dispersions for incorporation of a variety 
of lipophilic bioactive compounds in functional beverages. A further study may be needed to 
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